# Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/oncology-research-featuring-preclinical-and-clinical-cancer-therapeutics/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 0965-0407 |
| ISSNs | 0965-0407,1555-3906 |
| OpenAlex ID | https://openalex.org/S146643948 |
| Publisher | Cognizant Communication Corporation |

## Journal papers

- [Fibroblast Activation Protein-α-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade](https://scholariq.org/papers/fibroblast-activation-protein-positive-fibroblasts-promote-gastric-cancer/)
- [IL-2, TNF-α, and Leptin: Local Versus Systemic Concentrations in NSCLC Patients](https://scholariq.org/papers/il-2-tnf-and-leptin-local-versus-systemic-concentrations-in-nsclc-patients/)
- [miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2](https://scholariq.org/papers/mir-122-inhibits-hepatocarcinoma-cell-progression-by-targeting-lmnb2/)
- [TRAF4 Regulates Migration, Invasion, and Epithelial‐Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma](https://scholariq.org/papers/traf4-regulates-migration-invasion-and-epithelial-mesenchymal-transition-via/)
- [Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway](https://scholariq.org/papers/inhibition-of-mmp-2-expression-enhances-the-antitumor-effect-of-sorafenib-in/)
- [A Conjugate of Gemcitabine With Bisphosphonate (Gem/BP) Shows Potential as a Targeted Bone-Specific Therapeutic Agent in an Animal Model of Human Breast Cancer Bone Metastases](https://scholariq.org/papers/a-conjugate-of-gemcitabine-with-bisphosphonate-gem-bp-shows-potential-as-a/)
- [Swainsonine Inhibits Invasion and the EMT Process in Esophageal Carcinoma Cells by Targeting Twist1](https://scholariq.org/papers/swainsonine-inhibits-invasion-and-the-emt-process-in-esophageal-carcinoma-cells/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.